Results for rel:watson.com
-
watsonchampionsclub.com
Watson Pharmaceuticals is now Actavis
Watson Pharmaceuticals is now Actavis plc (NYSE: ACT), a global, integrated specialty pharmaceutical company.
-
watsonpharmcommunication.com
Watson Pharmaceuticals is now Actavis
Watson Pharmaceuticals is now Actavis plc (NYSE: ACT), a global, integrated specialty pharmaceutical company.
-
watson.com
Watson Pharmaceuticals Inc. Is Now Actavis Inc. - Actavis
Actavis (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.
-
actavisspecialtypharma.com
Actavis Specialty Pharmaceuticals Co., Canada
Actavis Specialty Pharmaceuticals Co., formerly Watson Pharma Company, is the Canadian subsidiary of Actavis, Inc. (NYSE: ACT). We are engaged in the marketing, sale and distribution of branded pharmaceutical products within the Canadian market.
-
actavisspecialtypharmaceuticals.com
Actavis Specialty Pharmaceuticals Co., Canada
Actavis Specialty Pharmaceuticals Co., formerly Watson Pharma Company, is the Canadian subsidiary of Actavis, Inc. (NYSE: ACT). We are engaged in the marketing, sale and distribution of branded pharmaceutical products within the Canadian market.
-
actavisspecialtypharmaceuticalsco.com
Actavis Specialty Pharmaceuticals Co., Canada
Actavis Specialty Pharmaceuticals Co., formerly Watson Pharma Company, is the Canadian subsidiary of Actavis, Inc. (NYSE: ACT). We are engaged in the marketing, sale and distribution of branded pharmaceutical products within the Canadian market.
-
watson-pharmaceuticals.com
Actavis - a global, integrated specialty pharmaceutical company - Actavis
Actavis plc (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.
-
Watson Pharmaceuticals is now Actavis
Watson Pharmaceuticals is now Actavis plc (NYSE: ACT), a global, integrated specialty pharmaceutical company.
-
Watson Pharmaceuticals is now Actavis
Watson Pharmaceuticals is now Actavis plc (NYSE: ACT), a global, integrated specialty pharmaceutical company.
-
Watson Pharmaceuticals Inc. Is Now Actavis Inc. - Actavis
Actavis (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.
-
Actavis Specialty Pharmaceuticals Co., Canada
Actavis Specialty Pharmaceuticals Co., formerly Watson Pharma Company, is the Canadian subsidiary of Actavis, Inc. (NYSE: ACT). We are engaged in the marketing, sale and distribution of branded pharmaceutical products within the Canadian market.
-
Actavis Specialty Pharmaceuticals Co., Canada
Actavis Specialty Pharmaceuticals Co., formerly Watson Pharma Company, is the Canadian subsidiary of Actavis, Inc. (NYSE: ACT). We are engaged in the marketing, sale and distribution of branded pharmaceutical products within the Canadian market.
-
Actavis Specialty Pharmaceuticals Co., Canada
Actavis Specialty Pharmaceuticals Co., formerly Watson Pharma Company, is the Canadian subsidiary of Actavis, Inc. (NYSE: ACT). We are engaged in the marketing, sale and distribution of branded pharmaceutical products within the Canadian market.
-
zdravljeleskovac.com
Actavis Srbija | Početna
Actavis Srbija je jedna od vodecih generickih farmaceutskih kompanija na svetu, sa snaznim sistemom razvoja i registracije.
-
watson-pharma.com
Actavis - a global, integrated specialty pharmaceutical company - Actavis
Actavis plc (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.
-
watson-pharmaceutical.com
Actavis - a global, integrated specialty pharmaceutical company - Actavis
Actavis plc (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.
-
Actavis - a global, integrated specialty pharmaceutical company - Actavis
Actavis plc (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.
